TickerStat.comwe like data

Teva Pharmaceutical Industries Ltd (TEVA)

Price$36.36Cached quote
TEVANYSE
Loading local price history

Financial charts

Revenue

Net income

Free cash flow

Total cash / debt

CashTotal debt

Financial statements

17 annual periodsNewest to oldest
20252024202320222021202020192018201720162013201220112010200920082007
Revenue$17.26B$16.54B$15.85B$14.93B$15.88B$16.66B$16.89B$18.27B$21.85B$21.90B$20.31B$20.32B$18.31B$16.12B$16.12B$11.09B$9.41B
Gross profit$8.94B$8.06B$7.64B$6.97B$7.59B$7.73B$7.54B$8.30B$10.62B$11.65B$10.71B$10.65B$9.52B$9.06B$7.37B$5.97B$4.88B
Gross margin51.79%48.74%48.25%46.72%47.83%46.38%44.63%45.41%48.57%53.20%52.71%52.43%51.96%56.23%45.70%53.84%51.84%
Research & development$1.01B$998.0M$953.0M$838.0M$967.0M$997.0M$1.01B$1.21B$1.78B$2.08B$1.43B$1.36B$1.09B$951.0M$825.0M$786.0M$581.0M
Operating expenses$6.78B$8.37B$7.21B$9.17B$5.88B$11.30B$7.98B$9.93B$28.10B$9.50B$9.06B$8.45B$6.41B$5.19B$4.96B$4.82B$2.48B
Operating income$2.16B−$303.0M$433.0M−$2.20B$1.72B−$3.57B−$443.0M−$1.64B−$17.48B$2.15B$1.65B$2.21B$3.11B$3.87B$2.40B$1.15B$2.40B
Operating margin12.50%−1.83%2.73%−14.72%10.81%−21.44%−2.62%−8.96%−80.01%9.83%8.12%10.85%16.98%24.01%14.92%10.33%25.46%
EBITDA$3.16B$756.0M$1.59B−$889.0M$3.05B−$2.02B$1.28B$205.0M−$15.37B$3.68B$3.29B$3.91B$4.18B$4.85B$3.31B$1.64B$2.89B
EBITDA margin18.30%4.57%10.01%−5.96%19.18%−12.10%7.57%1.12%−70.34%16.79%16.20%19.26%22.82%30.07%20.55%14.75%30.76%
Net income$1.41B−$1.64B−$559.0M−$2.45B$417.0M−$3.99B−$999.0M−$2.15B−$16.27B$329.0M$1.27B$1.96B$2.76B$3.33B$2.00B$609.0M$1.91B
Net profit margin8.17%−9.91%−3.53%−16.39%2.63%−23.95%−5.92%−11.77%−74.43%1.50%6.25%9.66%15.07%20.66%12.41%5.49%20.34%
Basic EPSper basic share$1.23-$1.45-$0.50-$2.20$0.38-$3.64-$0.91-$2.35-$16.26$0.07$1.49$2.25$3.10$3.72$2.29$0.78$2.49
Diluted EPSper diluted share$1.21-$1.45-$0.50-$2.20$0.38-$3.64-$0.91-$2.35-$16.26$0.07$1.49$2.25$3.09$3.67$2.23$0.75$2.36
Review official source filings ↗

Owners

Reported shareholders

Reference date Jun 30, 2026

Reported holdings Number of shares

View holders
Top 20 reported holders of TEVA
HolderShares held
BlackRock, Inc.
63.89M
Harel Insurance Investments & Financial Services Ltd.
48.14M
Phoenix Financial Ltd.
42.93M
WCM INVESTMENT MANAGEMENT, LLC
41.32M
Clal Insurance Enterprises Holdings Ltd
40.6M
MENORA MIVTACHIM HOLDINGS LTD.
39.85M
Migdal Insurance & Financial Holdings Ltd.
38.92M
NORGES BANK
32.3M
FMR LLC
30.26M
Lingotto Investment Management LLP
20.21M
STATE STREET CORP
18.94M
Rubric Capital Management LP
15.58M
Capital World Investors
12.54M
Altshuler Shaham Ltd
12.47M
GEODE CAPITAL MANAGEMENT, LLC
11.61M
MEITAV INVESTMENT HOUSE LTD
9.95M
NORTHERN TRUST CORP
7.96M
WELLINGTON MANAGEMENT GROUP LLP
7.67M
JPMORGAN CHASE & CO
6.98M
MORGAN STANLEY
6.97M

Bars compare reported share counts. A matching total for this share class and reporting period is unavailable, so percentages are not shown.

Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data

Insider buys & sells

Jul 1, 2024–Jun 30, 2026
Buys1$21.0K disclosed value
Sells (SEC code S)83$125.15M disclosed value
84 recent transactions
TransactionInsiderTypeSharesPriceValueOwned after
Jun 18, 2026Form 4Shields MatthewEVP, Global OperationsSellOrdinary Shares10.0K$32.19$321.5K0
Jun 11, 2026Form 4 · 10b5-1Kalif Eliyahu SharonEVP, Chief Financial OfficerSellOrdinary Shares106.6K$34.10$3.63M65.6K
Jun 5, 2026Form 4 · 10b5-1Francis Richard DPresident and CEOSellOrdinary Shares6.2K$34.35$211.4K1.18M
Jun 3, 2026Form 4 · 10b5-1Shields MatthewEVP, Global OperationsSellOrdinary Shares16.2K$32.87$532.3K10.0K
May 14, 2026Form 4 · 10b5-1Lippman EvanEVP, Business DevelopmentSellOrdinary Shares35.9K$35.58$1.28M44.2K
Review ownership filings at SEC.gov ↗

Community posts

View community

It’s quiet here.

No posts about TEVA yet. Start the conversation.

Write the first post